4.5 Article

Impact of combined sensory impairments on health-related quality of life

期刊

QUALITY OF LIFE RESEARCH
卷 24, 期 9, 页码 2099-2103

出版社

SPRINGER
DOI: 10.1007/s11136-015-0941-7

关键词

Auditory impairment; Olfactory impairment; Gustatory impairment; Visual impairment; Combined impact; SF-36

资金

  1. German Migraine and Headache Society (DMKG)
  2. Almirall
  3. AstraZeneca
  4. Berlin-Chemie
  5. Boehringer
  6. Boots Health Care
  7. GlaxoSmithKline
  8. Janssen Cilag
  9. McNeil Pharma
  10. MSD Sharp Dohme
  11. Pfizer

向作者/读者索取更多资源

Purpose To analyse the impact of single/combined sensory impairment on health-related quality of life (HRQOL). Methods Data from 1102 participants (mean age = 51.4 - years) of the Dortmund Health Study were analysed. HRQOL was assessed by the Short Form 36 Health Survey (SF-36). Sensory impairment was measured with validated tests. Each impairment variable was coded into four categories (no impairment, mild, moderate, and severe impairment). Data were analysed with general linear models adjusted for possible confounders. The reference category was the group of no sensory impairment. Results Sensory impairments did not influence the mental component score (MCS). Severe auditory impairment (-3.7, 95 % CI -6.3, -1.2) and olfactory impairment (-3.3, 95 % CI -5.6, -1.1) were related to a reduction in the physical component score (PCS). Auditory plus visual and gustatory plus visual impairments had a stronger effect on PCS than the respective impairments alone. For most of the other impairment combinations, additive effects were observed. Conclusions Sensory impairments reduced self-reported physical but not mental health scores. Combined sensory impairment worsened the impact of single sensory impairment on health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据